UK markets open in 4 hours 27 minutes
NIKKEI 225
37,801.10 +172.62 (+0.46%) HANG SENG
17,565.24 +280.70 (+1.62%) CRUDE OIL
83.84 +0.27 (+0.32%) GOLD FUTURES
2,347.20 +4.70 (+0.20%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,516.21 +123.06 (+0.24%)
Gilead Sciences, Inc. (GILD.MX)
Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
At close: 01:41PM CST
| Previous close | 1,139.94 |
| Open | 1,168.00 |
| Bid | 1,120.00 x 500000 |
| Ask | 1,200.00 x 300000 |
| Day's range | 1,121.75 - 1,168.00 |
| 52-week range | 1,121.75 - 1,551.92 |
| Volume | |
| Avg. volume | 222 |
| Market cap | 1.399T |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 14.69 |
| EPS (TTM) | 76.38 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 51.04 (4.48%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
Business WireGilead Sciences Announces First Quarter 2024 Financial Results
FOSTER CITY, Calif., April 25, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2024 results of operations.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.